LH
Labcorp Holdings, Inc.
NYSE · Healthcare · Medical - Equipment & Services · US
$368.16
+2.20%Year over year
Reported trailing growth
- Revenue
- +6.0%
- EBITDA
- +7.2%
- EBIT
- +21.7%
- EPS
- +19.6%
- Free cash flow
- -6.8%
- Operating cash flow
- +0.6%
Forward estimates
Based on analyst estimates
- Revenue
- +4.6%
- EBITDA
- +31.5%
- EPS
- +57.6%
Three-year CAGR
- Revenue
- +5.6%
- EBITDA
- +1.0%
- EBIT
- +1.8%
- Net income
- -11.8%
- EPS
- -9.1%
- Free cash flow
- -6.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026